(MedPage Today) — Daily treatment with a mineralocorticoid receptor antagonist flopped for reducing serious cardiac events in kidney failure patients on maintenance dialysis, a randomized trial found.
Among over 2,500 patients in the ACHIEVE…
Source link : https://www.medpagetoday.com/meetingcoverage/era/115970
Author :
Publish date : 2025-06-09 16:57:00
Copyright for syndicated content belongs to the linked Source.
